Navigation Links
SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
Date:7/26/2011

ared to the $7,000 unrealized loss for the six months ended June 30, 2010.

Net loss increased 15%, or $229,000, to $1.8 million for the six months ended June 30, 2011, compared to $1.5 million for the same period in 2010. The increase in net loss reflects higher general and administrative expenses and lower revenues.  

About SCOLR Pharma:Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented Controlled Delivery Technology (CDT) platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

This press release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including statements concerning the advancement of the Company's nutritional business, the use of proceeds from a financing transaction, and anticipated orders of its nutritional products.  These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future.  A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the Company's ability to manage expenses, generate revenue and/or unanticipated changes in the timing, amount or terms of orders for its nutritional products.  Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
2. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
3. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
4. SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
5. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
6. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
7. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
8. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
9. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
10. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
11. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21. Mai 2013 Der Vorstand ... Firmen OMNIlife science® Inc., Enztec Ltd. und Praxim ... neue, erfahrene Mitglieder in die Führungsriege gewählt. ... erfahrene Führungspersönlichkeit aus der Orthopädie, wird die ... Johnson , anerkannter Experte für medizinische ...
(Date:5/21/2013)... 2013  LCA-Vision Inc. (NASDAQ: LCAV ), a ... Plus ® brand, announces that all nominees to the company,s ... annual meeting of stockholders.  These Directors are: , ... Bahl & Gaynor Investment Counsel , John ... Edgar F. Heizer III , Chairman of ...
(Date:5/21/2013)... Mass. , May 21, 2013 /PRNewswire/ ... research and advisory firms for pharmaceutical and ... an emerging agent on key efficacy endpoints, ... progression, has the most influence over surveyed ... advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast cancer. ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
... May 23, 2011 Reportlinker.com announces that ... in its catalogue: Advanced ... http://www.reportlinker.com/p0507254/Advanced-Digital-Medical-Equipment-Products-Market .html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... sizes the advanced medical device markets, particularly ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... of Water and Wastewater Management in ... http://www.reportlinker.com/p0506839/Global-Water-Market-Outlook-Strategic-Analysis-of-Water-and-Wastewater-Management-in-the-Pharmaceutical-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Water_dis This ...
Cached Medicine Technology:Reportlinker Adds Advanced Digital Medical Equipment Products Market 2Reportlinker Adds Advanced Digital Medical Equipment Products Market 3Reportlinker Adds Advanced Digital Medical Equipment Products Market 4Reportlinker Adds Advanced Digital Medical Equipment Products Market 5Reportlinker Adds Advanced Digital Medical Equipment Products Market 6Reportlinker Adds Advanced Digital Medical Equipment Products Market 7Reportlinker Adds Advanced Digital Medical Equipment Products Market 8Reportlinker Adds Advanced Digital Medical Equipment Products Market 9Reportlinker Adds Advanced Digital Medical Equipment Products Market 10Reportlinker Adds Advanced Digital Medical Equipment Products Market 11Reportlinker Adds Advanced Digital Medical Equipment Products Market 12Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry 2Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry 3Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry 4
(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...
(Date:5/21/2013)... May 21, 2013 According to a May ... the Use of Botox,” Botox injections have become ... approval in 2002 (Go to goo.gl/8iYbD). Although it is mostly ... with men. The injection makes facial wrinkles less visible by ... last for about three months. This means that people who ...
(Date:5/21/2013)... May 21, 2013 Phoseon Technology will ... at the 20th Annual IMI European Ink Jet Conference ... market leader, Phoseon continues to invest in product development ... adoption of UV LED curing in printing applications. ... on the market offering both air cooled and water ...
(Date:5/21/2013)... MedMar Healing Center announces their participation in the ... Twenty-eight businesses, including MedMar Healing Center, doctors, and clubs, are ... is to raise food to help area kids who have ... recent years. , “We like being able to give ... Douglas Chloupek of MedMar Healing Center. “Taking part in the ...
(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3
... problems faced by youngsters with the disease , THURSDAY, July ... more likely to be overweight than those without the disease, ... The finding is from a major study that explored the ... a less common form of the disease that usually shows ...
... the launch of (RED)ZONES at the first U2 360 Degrees concert ... rapturous sold out crowd of 90,000 fans. , , ... will be present throughout the U2 tour. The tickets for ... the ticket sales going to the Global Fund to help fund ...
... 2 "If recent reports of DEA intervention are accurate, ... Diversion unit, and it won,t end there. The pharmacists who ... as will everyone whose name is associated with any of ... , Mr. Mullin won full federal jury acquittal at ...
... DUBLIN, Ohio, July 2 Cardinal Health today announced that ... effective upon the completion of the planned spinoff of CareFusion ... board for personal reasons after 22 years of service to ... Downey is the former chairman and chief executive officer of ...
... committee,s recommendations to the U.S. Food and Drug Administration (FDA) to put ... from the American Academy of Pain Medicine (AAPM), ... The American Academy of Pain Medicine (AAPM), which ... Pain Medicine, supports the safe and responsible, ...
... plug a Percocet-Vicodin gap, experts say, , THURSDAY, July 2 ... which a U.S. health advisory panel has urged, would not ... , The reason, they say, is that other options are ... made its recommendation Tuesday. It followed the release in May ...
Cached Medicine News:Health News:Kids With Type 1 Diabetes Often Overweight 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3Health News:DEA Will Play Hardball in Investigating Michael Jackson's Doctors 2Health News:Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years 2Health News:Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 2Health News:If 2 Painkillers Are Banned, What Next? 2Health News:If 2 Painkillers Are Banned, What Next? 3Health News:If 2 Painkillers Are Banned, What Next? 4
... diagnosis is generally confirmed by a positive heterophil ... however, is not indicated by the heterophil antibody ... - 20 percent of children. Detection and ... fully ascertain the stage of EBV infection. ...
... Biopsy Instrument and Needle is specially designed ... a large quality, reliable core sample. All ... ultra-sharp tips and polished surfaces for smooth ... biopsy systems and needle sizes assures an ...
... to bring efficiency and quality to routine ... superior technology of fluorescent flow cytometry with ... sampling or batch processing are easily accommodated ... in high volume laboratories. Fluorescent flow ...
... System incorporates a translucent inner sleeve into ... that each needle load matches the proper ... preloaded needle options, the IsoSleeve™ system allows ... giving you confidence that the needle load ...
Medicine Products: